Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evolution of L74V or K65R Mutations in VIremic Subjects on TDF or ABC (EVITA)

Trial Profile

Evolution of L74V or K65R Mutations in VIremic Subjects on TDF or ABC (EVITA)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Nov 2006

At a glance

  • Drugs Abacavir; Emtricitabine; Emtricitabine/tenofovir disoproxil fumarate; Lamivudine; Lamivudine/abacavir; Tenofovir disoproxil fumarate
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms EVITA
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 21 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top